MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopa-responsive dystonia(DRD)"

  • 2026 International Congress

    Intrafamilial Phenotypic Diversity Associated with Coexisting LRRK2 G2385R and a Novel GCH1 Variant: A Case Report

    CE. Wang, YF. Sung (Taipei, Taiwan)

    Objective: To describe intrafamilial phenotypic variability associated with the coexisting LRRK2 G2385R and a novel GCH1 variant in a family presenting with parkinsonism and dystonia…
  • 2026 International Congress

    THD (Tyrosine Hydroxylase Deficiency) in a 39-Year-Old Woman with Early-Onset Dystonia

    T. Le (Dallas, USA)

    Objective: To report a case of tyrosine hydroxylase deficiency (THD), a rare neurometabolic disorder that disrupts catecholamine biosynthesis. This case report highlights common neurologic abnormalities,…
  • 2026 International Congress

    Intra-familial phenotypic variability in a novel Autosomal dominant GCH1 variant

    W. Kamel, D. Al Mehatab, M. Mohamed Ibrahim, L. Bastaki (Beni-Suef, Egypt)

    Objective: To report a family with a novel variant of the GCH1 gene presenting as early-onset DOPA-responsive dystonia (DRD) and late-onset Parkinson’s disease. Background: Autosomal…
  • 2025 International Congress

    30-year Delayed Diagnosis of Juvenile Parkinson’s Disease in a Patient Misdiagnosed with Dopa-responsive Dystonia

    N. Mohammed, J. Chen (New Brunswick, USA)

    Objective: To report a case of Juvenile Parkinson’s Disease (JP) misdiagnosed as dopa-responsive dystonia (DRD) and to emphasize the importance of early genetic testing in…
  • 2025 International Congress

    When Dystonia mimics Multiple Sclerosis : A Familial case series of GCH1 misdiagnosis

    B. Perraud, I. Beaulieu-Boire (Sherbrooke, Canada)

    Objective: To describe phenotypic variability associated with a GCH1 mutation and increase clinical suspicion in patients with atypical phenotypes. Background: Dopa-responsive dystonia (DRD) is a genetic disorder most commonly…
  • 2025 International Congress

    Novel presentation of PRRT2 with paroxysmal dystonia and responsive to carbidopa/levodopa.

    J. Cremin-Endes, M. Walsh, M. Higginson, N. Hack (San Diego, USA)

    Objective: Present a novel case of PRRT2 positive PKD presenting with paroxysmal dystonia that responded to treatment with carbidopa levodopa. First report in the literature.…
  • 2025 International Congress

    Tyrosine Hydroxylase Deficiency and Absence Epilepsy: An Association or Mere Coincidence?

    L. Rieder, A. Schuh, C. Rieder, M. Bianchin (Canoas, Brazil)

    Objective: To explore the possible relationship between tyrosine hydroxylase deficiency (THD) and absence epilepsy, with a specific focus on the role of dopamine in the…
  • 2025 International Congress

    National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

    K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)

    Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…
  • 2024 International Congress

    Startle Reflex in CTNNB1 Mutations: A diagnostic Clue

    S. Nagaratnam, D. Wilson, M. Garcia, J. Qiu, D. Hadi, S. Mohammad, H. Morales Briceno (Westmead, Australia)

    Objective: To describe two patients with CTNNB1 mutation with a startle reflex, an underrecognised clinical sign. Background: CTNNB1 mutations is an increasingly recognised cause of…
  • 2024 International Congress

    Alterations of NAD metabolism in symptomatic and asymptomatic carriers of pathogenic GCH1 variant

    J. Prasuhn, L. van Well, F. Hamami, C. Klein, A. Weissbach, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate whether carriers of pathogenic GCH1 variant reveal lower NAD levels in the basal ganglia or the cerebellum compared to variant-free controls. Background:…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley